Projects
The pharmaceutical projects listed in this phase are those that receive periodic global announcements.
Samsung Biologics Expands U.S. Manufacturing with $280 Million Acquisition of Human Genome Sciences
Samsung Biologics has announced the acquisition of Human Genome Sciences from GSK, marking its first USbased manufacturing site The Rockville, Maryland facility will expand the companys global manufacturing
INCOG BioPharma Plans Major $200 Million Facility Expansion in Indiana
INCOG BioPharma Services has announced a major $200 million expansion of its injectable drug manufacturing facility in Fishers, Indiana The investment will significantly increase production capacity and support longterm growth, positioning the site as a leading global hub for injectable biopharmaceutical manufacturing
AstraZeneca Expands U.S. Manufacturing Capacity with $2B Maryland Investment
AstraZeneca has announced plans to invest $2 Billion in expanding its manufacturing operations in Maryland, strengthening its presence in one of the United States leading life sciences regions
Moderna Expands U.S. Manufacturing Capabilities with $140M Investment
Moderna, Inc is expanding its US manufacturing capabilities by onshoring Drug Product production to its Moderna Technology Center MTC in Norwood, Massachusetts This development completes the companys
Eli Lilly to Expand European Footprint with $3B Oral Medicines Plant in Netherlands
Eli Lilly and Company plans to invest $3 billion in a new manufacturing facility in Katwijk, located within the Leiden Bio Science Park in the Netherlands
Eli Lilly Invests $1.2 Billion to Boost Oral Drug Production in Puerto Rico
Eli Lilly and Company has announced plans to invest more than $12 billion to expand and modernise its Lilly del Caribe manufacturing facility in Carolina, Puerto Rico The investment aims to strengthen the companys production
Merck Breaks Ground on $3 Billion Pharmaceutical Manufacturing Center in Virginia
Merck has started construction on a $3 billion Centre of Excellence for Pharmaceutical Manufacturing in Elkton, Virginia The 400,000squarefoot facility is part of Mercks longterm plan to expand domestic
AstraZeneca Announces $4.5B Investment in Virginia Production Facility
AstraZeneca has announced a $45 billion investment in its new manufacturing facility at Rivanna Futures in Albemarle County, Virginia
AbbVie Invests $70 Million to Boost U.S. Biologics Manufacturing & R&D
AbbVie has started construction on a $70 million expansion at its AbbVie Bioresearch Center ABC in Worcester, Massachusetts The centre serves as a hub for biologics research, development, and manufacturing This expansion is part of AbbVies wider
Amgen Strengthens U.S. Footprint with $650M Investment
Amgen has announced a $650 million expansion of its US manufacturing network, aimed at increasing production capacity and integrating advanced technologies throughout its operations
